CogLeap (Shanghai) Education Technology Files IPO Prospectus: Pioneering Digital Therapeutics for ADHD with Hallowell-Backed Solutions

In 2023, China International Capital Corporation (CICC) Qixin released a set of data on the number of patients with Attention-Deficit/Hyperactivity Disorder (ADHD). The data showed that from 2015 to 2022, the global number of ADHD patients aged 6–17 increased from 100 million to 110 million, with a compound annual growth rate (CAGR) of 1.5%. In China, the overall prevalence of ADHD among children and adolescents is relatively high, reaching 6%, with more than 23 million existing pediatric and adolescent ADHD patients.

Although ADHD is the most prevalent neurodevelopmental disorder among school-aged children, affecting a large patient population, its etiology remains intricate and multifaceted. For many years, clinical management has relied primarily on pharmacological and non-pharmacological interventions; however, both approaches have certain limitations.

Among these, pharmacological therapy predominantly utilizes stimulant medications, which offer rapid onset of action but are associated with relatively pronounced side effects. Within non-pharmacological approaches, behavioral intervention training imposes stringent requirements on the therapeutic environment, instructor qualifications, and standardization, thereby limiting the feasibility of institutional implementation and resulting in low adoption rates. Treatments such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) lack sufficient evidence-based medical support, and controversies persist regarding issues such as the long-term effects of electromagnetic stimulation on the brain.

It is for this reason that efforts are underway worldwide to discover novel treatments for ADHD. For instance, China has developed traditional Chinese medicine (TCM) therapies, while overseas markets have introduced exercise therapy, dietary therapy, and other approaches. Currently, digital therapeutics represent the latest international research advancement, with ADHD digital therapeutic products progressively gaining regulatory approval around the globe. Grounded in evidence-based medicine and artificial intelligence technologies, digital therapeutics offer ease of use, standardization, professionalism, and scientific rigor. They not only circumvent the side effects associated with pharmacological treatments but also address challenges inherent in behavioral training, such as inconsistency, lack of standardization, implementation difficulties, and stringent environmental requirements, thereby enabling effective treatment of ADHD.

As early as 2017,SHANGHAI COGNITIVE CENTER LIMITED(hereinafter referred to as “Cognitive Center”) had already recognized the advantages of digital therapeutics in the treatment of ADHD. In January of the same year,The Company Launches the VRAT Virtual Reality Attention Assessment System, and pilot testing was conducted at Taipei Veterans General Hospital and the Shanghai Mental Health Center. Subsequently, VRAT was successively applied in the Computer Cognitive Neuroscience Laboratory at Stanford University and the Duke University Health System. Building on this foundation, the company gradually initiated product certification and commercialization efforts, continuously expanding its product portfolio,Build a closed-loop digital attention solution encompassing the HFS HarshYou Brain Training System, professional training and certification systems, and more.

SHANGHAI COGNITIVE CENTER Closed-Loop Service Process

“Hundreds of millions of children and adolescents in China face challenges related to mental and emotional health, yet the number of experts available to assist them is extremely limited. SHANGHAI COGNITIVE CENTER LIMITED aims to empower mental healthcare through technology by introducing the world’s most advanced assessment tools and non-pharmacological interventions to China. Our mission is to ensure that all children and adolescents can access the best possible support, anytime and anywhere, helping them reclaim their healthy selves, learn with joy, and grow with confidence!”

Guided by this philosophy, SHANGHAI COGNITIVE CENTER LIMITED has partnered with Dr. Edward M. Hallowell, a renowned authority on attention at Harvard University, to jointly advance the development of digital interventions for Attention-Deficit/Hyperactivity Disorder (ADHD).

Dr. Hallowell, Harvard University’s Leading Authority on Attention

As a co-founder of Shanghai Cognitive Center Limited, Dr. Hallowell provides the company with intervention concepts and professional technical support for ADHD. As an expert in the field of ADHD, Dr. Hallowell served as a professor at Harvard Medical School for over 20 years and established clinics in Boston, New York, Seattle, San Francisco, and other cities, providing effective assistance to tens of thousands of patients with ADHD. In addition, he has authored 21 popular books on attention deficit hyperactivity disorder (ADHD), among which Driven to Distraction has sold more than 2 million copies worldwide and is hailed as a classic in the field of distractibility.

Cognitive CenterBased on Dr. Hallowell’s “Theory of Developmental Strengths in Children,” we have established a theoretical and methodological framework for Attention-Deficit/Hyperactivity Disorder (ADHD) intervention centered on “Child Nature–Strength Orientation.” By integrating cutting-edge neuroscience technologies with artificial intelligence algorithms, this framework has been consolidated into the globally unique HFS Ha氏 Child Brain Optimization Training System.Promoting the Application and Popularization of Non-Pharmacological Interventions for ADHD.

HFS Training SystemNon-pharmacological interventions are provided for children with attention, emotional regulation, or behavioral issues. This training system is based on the principles of brain development and neuroplasticity. It utilizes bone-conduction headphones and specially processed music to engage the body and nervous system as a whole in multimodal sensory enhancement involving visual, auditory, and motor modalities, thereby promoting neuronal development and improving cognitive abilities, efficient information processing, and emotional regulation in children and adolescents.

HFS Training System: Six-Dimensional Development Framework

The HFS Training System centers on Ha Shi You Brain Training as its core intervention, supplemented by home-based auxiliary interventions. It supports the holistic development of children with ADHD across multiple dimensions, including motor skills, nutrition, sleep, parenting, and school support. While the system primarily targets attention deficits in children and adolescents, existing clinical data and research findings demonstrate that it also yields significant improvements in sensory-motor skills, fine and gross motor skills (including bodily functions and motor planning abilities), auditory processing sensitivity, emotional regulation, and social skills (such as eye contact).

Training Cases

Furthermore, SHANGHAI COGNITIVE CENTER LIMITED also providesHFS Ha's You Brain Training Instructor Certification SystemCurrently, this training system has obtained continuing education accreditation from the American Psychological Association (APA). Participants need only complete the corresponding online courses and pass the assessments and supervision requirements for the designated number of hours to receive a certificate of continuing education credits issued by the American Psychological Association (APA).

Certificate Template Reference

In 2020, the HFS Haishiyou Brain Training System was launched and entered frontline clinical application in public and private hospitals across China. In 2021, the first batch of HFS Trainer Training and Certification Programs was initiated. In 2023, HFS trainer training began to target parents of children with ADHD, and has since trained over one hundred home-based trainers.

While introducing advanced international treatment concepts and technologies, Cognitive Center emphasizes independent research and development and innovation. The company’s Chief Scientist, Professor Skip Rizzo, serves as the Director of the Center for Virtual Reality Medicine at the University of Southern California. A pioneer in applying virtual reality technology to psychotherapy, he was awarded the 2010 Outstanding Contribution to Trauma Therapy Award by the American Psychological Association for his research on virtual reality exposure therapy for post-traumatic stress disorder (PTSD). Under the leadership of Professor Skip Rizzo, the company’s technical R&D team continuously optimizes and refines its product line to meet the needs of diverse patient populations.

Professor Skip Rizzo, Chief Scientist at SHANGHAI COGNITIVE CENTER LIMITED

In addition to the HFS training system, SHANGHAI COGNITIVE CENTER LIMITED has also developed the VRAT Virtual Reality Attention Assessment System.

VRAT SystemVirtual reality technology can be utilized to simulate classroom scenarios familiar to children. By wearing VR headsets, children complete the 13-minute AX-CPT (a continuous attention test) neurocognitive task within a virtual classroom environment. This approach provides authentic feedback on children’s behavioral performance in school settings, controls environmental variables, and minimizes human-induced biases. It evaluates children’s attention levels and motor performance across six dimensions: goal-directed attention, behavioral self-control, sustained attention, reaction speed, response stability, and discrimination ability.

VRAT Virtual Reality Attention Assessment System Example

During task completion, the VRAT assessment system captures real-time kinematic data from children’s head and hand movements. Leveraging AI algorithms, it analyzes attention levels and motor behavioral performance, while comparing results against age- and gender-matched normative data to generate comprehensive, professional analytical reports. This facilitates early identification and subtype diagnosis of ADHD. Currently, VRAT has submitted an application to the U.S. FDA.

Sample Assessment Report

If digital therapeutics can demonstrate significant efficacy in both theory and practice, they will undoubtedly become a highly promising treatment modality and high-quality product. SHANGHAI COGNITIVE CENTER LIMITED has established itself in the field of ADHD by developing a closed-loop digital attention solution, thereby filling the gap in China for adjunctive diagnosis and personalized intervention of ADHD.

In summary, SHANGHAI COGNITIVE CENTER LIMITEDCore Product: A medical-grade digital healthcare solution for psychiatric disorders, using childhood ADHD as the entry point, covering the entire process from assessment and auxiliary diagnosis to personalized, comprehensive intervention and follow-up evaluation.including the VRAT Virtual Reality Attention Assessment System (a CPT-based auxiliary diagnostic tool for ADHD) with exclusive patents, the HFS Training System powered by AI algorithms (targeting ADHD, autism spectrum disorder, speech and language developmental delays, etc.), and a professional training program certified by the American Psychological Association (APA).

Furthermore, the company has alreadyThe healthcare and education sectors have established collaborations with relevant institutions to jointly explore new methods and technologies for ADHD treatment, includingZhujiang Hospital of Southern Medical University, The Eighth Affiliated Hospital of Sun Yat-sen University, Guangzhou Medical University Brain Hospital, Xi'an Children's Hospital, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen Second People's Hospital, as well as Fudan University, Sun Yat-sen University, Leshan Normal University, and many other institutions in ChinaRenowned Medical Institutions, Research Institutes, and Universities. To ensure the safety and efficacy of its products, Shanghai Cognitive Center Limited strictly adheres to relevant national regulations and standards, conducting product efficacy certification and clinical studies.

The company has obtained multiple domestic and international certifications and awards. The paper “Normative Date for a Next Generation Virtual Classroom For Attention Assessment in Children with ADHD and Beyond!” by the SHANGHAI COGNITIVE CENTER LIMITED team won the Best Paper Award at the 13th ICDVRAT.

As the exclusive partner of Dr. Hallowell in China, SHANGHAI COGNITIVE CENTER LIMITED will continue to expand the scope of its product applications, gradually extending them from the field of ADHD to related conditions such as developmental delays and emotional or psychological disorders in children.